Author

K. L. Mossman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:CUT&Tag· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Gillgrass· 1 shared A. Kang· 1 shared A. Marzok· 1 shared A. Phelps· 1 shared A. Zganiacz· 1 shared A. Zhang· 1 shared B. D. Lichty· 1 shared F. Smaill· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Gillgrass

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Long dsRNA mediated RNA interference (dsRNAi) is antiviral in interferon competent mammalian cells

S. L. Semple, R. A. Jacob, K. L. Mossman, S. J. DeWitte-Orr

The paper shows that low-concentration dsRNA can inhibit viral replication in IFN-competent mammalian cells via RNAi, independent of IFN induction.

bioRxiv · Jan 14, 2022 · PreprintImmunology

Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2

S. Afkhami, M. R. D'Agostino, A. Zhang, H. D. Stacey, A. Marzok, A. Kang, R. Singh, J. Bavananthasivam, G. Ye, X. Luo, F. Wang, J. C. Ang, A. Zganiacz, U. Sankar, N. Kazhdan, , Z. Xing

This study evaluates a multivalent Ad-vectored vaccine delivered via respiratory mucosal route, showing robust protection against SARS-CoV-2 and variants in mice.

bioRxiv · Jul 16, 2021Immunology